New Variant of Coronavirus Leaves Hospitals Scrambling


British hospitals are canceling non-urgent procedures and scrambling to find space for COVID-19 patients as coronavirus cases continue to surge despite tough new restrictions imposed to curb a fast-spreading new variant of the virus.

Dr. Nick Scriven, immediate past president of the Society for Acute Medicine, said Monday that the rising number of hospitalized patients was “extremely worrying.”

“With the numbers approaching the peaks from April, systems will again be stretched to the limit,” he said.

British authorities are blaming a new variant of the coronavirus for soaring infection rates in London and southeast England.

They say the new version is more easily transmitted than the original, but stress there is no evidence it makes people sicker.

George Takei's Disgusting Take on Murder of Nursing Student Makes Himself Out to Be the Victim

In response, authorities have put a swath of England that’s home to 24 million people under restrictions that require nonessential shops to close, bar indoor socializing and allow restaurants and pubs only to operate for takeout.

Even so, hospital admissions for COVID-19 in southeast England are approaching or exceeding the levels seen at the first peak of the outbreak.

Government figures show 21,286 people were hospitalized with the coronavirus across the U.K. on Dec. 22, the last day for which data is available.

That is only slightly below the high of 21,683 COVID-19 patients who were recorded in U.K. hospitals on April 12.

Will you get the COVID-19 vaccine?

Dr. Katherine Henderson, president of the Royal College of Emergency Medicine, described her experience working in a hospital on Christmas Day as “wall-to-wall COVID.”

“The chances are that we will cope, but we cope at a cost,” Henderson told the BBC. “The cost is not doing what we had hoped, which is being able to keep non-COVID activities going.”

Britain has already recorded more than 70,000 deaths among people with the coronavirus, one of the highest tolls in Europe.

Cabinet Minister Michael Gove said more parts of England might have to be put into the toughest tier of restrictions if case numbers do not fall. Scotland, Wales and Northern Ireland also have implemented strong lockdown measures.

Still, there is rising confidence help could soon be on the way, with the expectation mounting that U.K. regulators may authorize a second coronavirus vaccine this week.

Taylor Swift's Dad Under Investigation for Alleged Assault in Australia

British media reports say the Medicines and Healthcare Products Regulatory Agency is likely to give the green light to a vaccine made by AstraZeneca and Oxford University.

The regulator authorized a jab made by U.S. pharmaceutical company Pfizer and German firm BioNTech on Dec. 2, making Britain the first country to gain access to a rigorously tested vaccine.

More than 600,000 people in the U.K. have received the first of the two shots needed of the vaccine.

If the AstraZeneca-Oxford vaccine is authorized this week, members of the public could start receiving it from Jan. 4.

Britain has ordered 100 million doses, compared to 40 million doses of the Pfizer-BioNTech shot.

The AstraZeneca-Oxford vaccine is considered a potential game-changer in global immunization efforts because it is less expensive than the Pfizer shot and does not need to be stored at freezer temperatures, making it easier to distribute.

But it had less clear-cut results from clinical trials than its main rivals.

Partial results suggest that the shot is about 70 percent effective for preventing illness from coronavirus infection, compared to the 95 percent efficacy reported for the Pfizer-BioNTech vaccine.

But the trials produced two different results based on the dosing regimen used.

Researchers said the vaccine protected against disease in 62 percent of those given two full doses and in 90 percent of those given a half dose followed by a full dose. However, the second group included only 2,741 people — too few to be conclusive.

The Western Journal has reviewed this Associated Press story and may have altered it prior to publication to ensure that it meets our editorial standards.

Truth and Accuracy

Submit a Correction →

We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

, , , , , ,
The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Their teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. They provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands. Photo credit: @AP on Twitter
The Associated Press was the first private sector organization in the U.S. to operate on a national scale. Over the past 170 years, they have been first to inform the world of many of history's most important moments, from the assassination of Abraham Lincoln and the bombing of Pearl Harbor to the fall of the Shah of Iran and the death of Pope John Paul.

Today, they operate in 263 locations in more than 100 countries relaying breaking news, covering war and conflict and producing enterprise reports that tell the world's stories.
New York City